Business
A New Era in Healthcare with Digital Health: Innovest Global Inc. (OTC: IVST), eWellness Healthcare, ResMed Inc. and Progressive Care Inc.
A New Era in Healthcare with Digital Health: Innovest Global Inc. (OTC: IVST), eWellness Healthcare, ResMed Inc. and Progressive Care Inc..
About this update from Ewellness Healthcare Corp
[{"type":"text","content":"\nNEW YORK and DELTA, British Columbia, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Investorideas.com, a leading investor news resource covering technology and healthcare stocks releases a snapshot looking at how healthcare is changing in the digital age.\n Investorideas recently reported on how Digital Health technologies enabling out-of-hospital care and monitoring are forecast to grow by 30 percent and cross the $25 billion mark. In the article, Kamaljit Behera, Industry Analyst, Transformational Health, said, \"In this highly digitized environment, artificial intelligence (AI) will permeate the life sciences ecosystem, and its use in healthcare IT (HIT) is likely to cross $1.7 billion by the end of 2019. AI-powered IT tools that manage payers and providers business risks in clinical, operational, financial and regulatory settings will especially find high uptake. Blockchain in healthcare is slowly starting to migrate from pilot proof of concept (PoC) to early commercial implementations.” Innovest Global Inc. (OTC: IVST), a conglomerate with operations in commercial and industrial products and services, biotechnology, construction and building materials is one such company focused on the future of Digital Health. Innovest recently provided a recap of the company’s solid performance, milestones and achievements in 2018 and their outlook for 2019. The letter recaps the journey from a seven-employee company at the beginning of 2018 that generated $58,000 in revenue, to ending 2018 on a $40 million annual revenue run-rate with a conglomerate of operating businesses spanning various industries and 75 employees. Management expects at least 20% organic growth for 2019. Daniel G. Martin, Founder, Chairman and CEO of Innovest commented, “We are the best-equipped company in biotech to help scientists and biotech companies achieve commercial success right now.” Martin continued, “Innovest Global’s Biotech Division seeks to grow by targeting companies with innovative and transformative technologies in the Digital Health and Medical Device space.  Nonetheless, we are also considering transformative technologies in stem cell biology and immunotherapy.  Digital Health is one of the fastest growing markets in biotech.  We seek to identify companies that have products in the market and are seeking...